Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Xtacy Therapeutics ( (TSE:LOAN) ) is now available.
Pegasus Mercantile Inc. has signed a CDN$2,000,000 convertible secured promissory note with Solo Beverage Company Inc. The agreement includes a two-year term at a 12% annual interest rate, with Pegasus having the option to convert the note at any time during the term. Additionally, Pegasus has secured stock warrants in Solo equivalent to 20% of the note’s value. This strategic investment aims to expand Solo’s reach, particularly through its newly acquired brand, The Classics, into markets in the USA, Europe, and South America.
More about Xtacy Therapeutics
Pegasus Mercantile Inc. is a prospect generator that provides financial, operational, and management assistance to high growth companies in the fast-growing consumer products market. The company focuses on global wellness and healthcare-related target companies.
YTD Price Performance: -20.0%
Average Trading Volume: 41,042
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.22M
See more insights into LOAN stock on TipRanks’ Stock Analysis page.